Inhibition of Notch1 reduces cancer stem cell function, reduces expression of Notch target genes HES1, HES5 and HEY-L, and reduces the population of CD44HiCD24low, a population identified as cancer stem cells [30–32]. This evidence concerns the gene HES5 and cancer.